531 related articles for article (PubMed ID: 21151200)
1. Oxidative stress in early diabetic nephropathy: fueling the fire.
Singh DK; Winocour P; Farrington K
Nat Rev Endocrinol; 2011 Mar; 7(3):176-84. PubMed ID: 21151200
[TBL] [Abstract][Full Text] [Related]
2. Role of oxidative stress in diabetic nephropathy.
Vasavada N; Agarwal R
Adv Chronic Kidney Dis; 2005 Apr; 12(2):146-54. PubMed ID: 15822050
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.
Yamagishi S; Fukami K; Ueda S; Okuda S
Curr Drug Targets; 2007 Aug; 8(8):952-9. PubMed ID: 17691932
[TBL] [Abstract][Full Text] [Related]
4. Nephropathy in diabetes.
Satirapoj B
Adv Exp Med Biol; 2012; 771():107-22. PubMed ID: 23393675
[TBL] [Abstract][Full Text] [Related]
5. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
6. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats.
Kowluru RA; Abbas SN; Odenbach S
J Diabetes Complications; 2004; 18(5):282-8. PubMed ID: 15337502
[TBL] [Abstract][Full Text] [Related]
7. The importance of diabetic nephropathy in current nephrological practice.
Locatelli F; Canaud B; Eckardt KU; Stenvinkel P; Wanner C; Zoccali C
Nephrol Dial Transplant; 2003 Sep; 18(9):1716-25. PubMed ID: 12937216
[TBL] [Abstract][Full Text] [Related]
8. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
[TBL] [Abstract][Full Text] [Related]
9. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
Chilelli NC; Burlina S; Lapolla A
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
[TBL] [Abstract][Full Text] [Related]
10. Anti-Oxidative Therapy in Diabetic Nephropathy.
Hernandez LF; Eguchi N; Whaley D; Alexander M; Tantisattamo E; Ichii H
Front Biosci (Schol Ed); 2022 May; 14(2):14. PubMed ID: 35730439
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in diabetic nephropathy.
Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
[TBL] [Abstract][Full Text] [Related]
12. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
Tonna S; El-Osta A; Cooper ME; Tikellis C
Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
[TBL] [Abstract][Full Text] [Related]
13. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
Sun YM; Su Y; Li J; Wang LF
Biochem Biophys Res Commun; 2013 Apr; 433(4):359-61. PubMed ID: 23541575
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C.
Ha H; Kim KH
Diabetes Res Clin Pract; 1999 Sep; 45(2-3):147-51. PubMed ID: 10588367
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.
Zabad IEM; Amin MN; El-Shishtawy MM
Life Sci; 2019 Dec; 239():117088. PubMed ID: 31759039
[TBL] [Abstract][Full Text] [Related]
17. The Role of Dietary Antioxidants on Oxidative Stress in Diabetic Nephropathy.
Gerardo Yanowsky-Escatell F; Andrade-Sierra J; Pazarín-Villaseñor L; Santana-Arciniega C; De Jesús Torres-Vázquez E; Samuel Chávez-Iñiguez J; Ángel Zambrano-Velarde M; Martín Preciado-Figueroa F
Iran J Kidney Dis; 2020 Mar; 14(2):81-94. PubMed ID: 32165592
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia to nephropathy via transforming growth factor beta.
Garud MS; Kulkarni YA
Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
20. Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.
Lindblom R; Higgins G; Coughlan M; de Haan JB
Rev Diabet Stud; 2015; 12(1-2):134-56. PubMed ID: 26676666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
